Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Breast Cancer Res Treat. 2016 Aug 10;159(2):335–345. doi: 10.1007/s10549-016-3910-0

Table 2.

Relative risks (RR) and 95% confidence intervals (95%CI) for breast cancer according to quintile of cumulative average of premenopausal whole grain and refined grain foods intake among women in the Nurses’ Health Study II

Quintile of intake
1 2 3 4 5 Ptrend
Cumulative average of premenopausal total whole grain-food intake

All cases
    Median intake, serving/day 0.2 0.5 0.7 1.0 1.5
    No. of cases/person-years 673/375,194 642/377,729 617/377,311 647/377,992 656/377,630
    Age-adjusted RR (95%CI) 1 0.99 (0.89–1.10) 0.95 (0.85–1.06) 1.01 (0.90–1.12) 1.01 (0.90–1.12) 0.76
    Multivariable RR (95%CI) 1 0.92 (0.83–1.03) 0.87 (0.77–0.97) 0.91 (0.81–1.02) 0.91 (0.81–1.03) 0.25

Premenopausal cases
    Median intake, serving/day 0.2 0.5 0.7 1.00 1.5
    No. of cases/person-years 386/234,866 339/236,307 343/236,657 322/236,936 329/236,277
    Age-adjusted RR (95%CI) 1 0.89 (0.77–1.03) 0.90 (0.77–1.04) 0.85 (0.74–0.99) 0.86 (0.74–1.00) 0.06
    Multivariable RR (95%CI) 1 0.88 (0.76–1.02) 0.87 (0.75–1.02) 0.83 (0.71–0.97) 0.82 (0.70–0.97) 0.03

Postmenopausal cases
    Median intake, serving/day 0.2 0.5 0.7 1.0 1.6
    No. of cases/person-years 223/105,700 243/106,194 216/106,298 233/106,309 254/106,231
    Age-adjusted RR (95%CI) 1 1.11 (0.92–1.33) 0.99 (0.82–1.20) 1.07 (0.89–1.29) 1.14 (0.95–1.37) 0.21
    Multivariable RR (95%CI) 1 1.05 (0.87–1.26) 0.91 (0.75–1.11) 0.99 (0.81–1.21) 1.06 (0.87–1.30) 0.61

Cumulative average of premenopausal total refined grain-food intake

All cases
    Median intake, serving/day 1.2 1.7 2.2 2.7 3.5
    No. of cases/person-years 684/376,472 677/377,439 642/377,614 638/377,317 594/377,014
    Age-adjusted RR (95%CI) 1 1.03 (0.92–1.14) 0.99 (0.89–1.10) 1.00 (0.89–1.11) 0.93 (0.83–1.03) 0.12
    Multivariable RR (95%CI) 1 0.97 (0.86–1.08) 0.92 (0.81–1.03) 0.93 (0.81–1.05) 0.88 (0.76–1.01) 0.06

Premenopausal cases
    Median intake, serving/day 1.3 1.8 2.2 2.7 3.5
    No. of cases/person-years 365/235,558 370/236,446 337/236,531 338/236,476 309/236,032
    Age-adjusted RR (95%CI) 1 1.03 (0.89–1.20) 0.98 (0.84–1.13) 0.99 (0.86–1.15) 0.92 (0.79–1.07) 0.20
    Multivariable RR (95%CI) 1 1.03 (0.88–1.20) 0.97 (0.83–1.15) 0.99 (0.83–1.18) 0.91 (0.75–1.11) 0.31

Postmenopausal cases
    Median intake, serving/day 1.2 1.7 2.1 2.6 3.4
    No. of cases/person-years 250/105,946 239/106,239 230/106,239 221/106,186 229/106,069
    Age-adjusted RR (95%CI) 1 0.97 (0.82–1.16) 0.94 (0.79–1.13) 0.92 (0.76–1.10) 0.93 (0.77–1.11) 0.34
    Multivariable RR (95%CI) 1 0.92 (0.76–1.11) 0.84 (0.69–1.03) 0.81 (0.65–1.00) 0.83 (0.66–1.04) 0.10

Multivariable model was stratified by age in months at start of follow-up and calendar year of the current questionnaire cycle and was simultaneously adjusted for smoking (never, past, current 1–14/day, current 15–24/day, current ≥25/day), race (white/non-white), parity and age at first birth (nulliparous, parity ≤2 and age at first birth <25 years, parity≤2 and age at first birth 25–<30 years, parity ≤2 and age at first birth ≥30 years, parity 3–4 and age at first birth <25 years, parity 3–4 and age at first birth 25–<30 years, parity 3–4 and age at first birth ≥30 years, parity ≥5 and age at first birth <25 years, parity ≥5 and age at first birth ≥25 years), height (<62, 62–<65, 65–<68, ≥68 inches), BMI at age 18 years (<18.5, 18.5–<22.5, 22.5–<25, 25.0–<30, ≥30.0 kg/m2), weight change since age 18 (continuous, missing indicator), age at menarche (<12, 12, 13, ≥14 years), family history of breast cancer (yes, no), history of benign breast disease (yes, no), oral contraceptive use (never, past, current), adult alcohol intake (nondrinker, <5, 5–<15,≥15 g/day), physical activity (quintile), energy intake (quintile). In postmenopausal women, we additionally adjusted for hormone use (postmenopausal never users, postmenopausal past users, postmenopausal current users), age at menopause (<45 years, 45 to 46 years, 47 to 48, 49 to 50 years, 51 to 52 years, ≥53 years). Among all women, we additionally adjusted for hormone use and menopausal status (premenopausal, postmenopausal never users, postmenopausal past users, postmenopausal current users, unknown menopausal status) and, age at menopause (premenopausal, unknown menopause, <45 years, 45 to 46 years, 47 to 48, 49 to 50 years, 51 to 52 years, ≥53 years).